JSPR
Jasper Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.71
+3.23%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-2248.5%
Return on equity
-269.2%
Return on assets
-3277.7%
Return on invested capital
0.00x
Asset turnover
-$60.3M
Cash from operations
$0.22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026